Managing Oral Care for Patients With Head and Neck Cancers
A review of the significance of oral and dental care for patients with head and neck cancer.
Head and Neck Cancer
New Dosing Regimen Approved for Erbitux in Colorectal, Head and Neck Cancer
The new dosing schedule is in addition to the approved weekly dosage regimen.
Endoscopic Surgery Improved OS for Locally Recurrent Nasopharyngeal Cancer
A team of investigators conducted a randomized controlled trial to assess outcomes following salvage endoscopic surgery vs radiation therapy in patients with resectable, locally recurrent nasopharyngeal cancer.
KESTREL Trial Testing Durvalumab With or Without Tremelimumab in HNSCC Misses OS End Points
Investigators of the phase 3 KESTREL trial recruited 823 patients with previously untreated recurrent or metastatic head and neck squamous cell carcinoma (HNSCC).
American Cancer Society 2021 Statistics Report Shows Continuous Decline in Cancer Mortality Rate, Illuminates Disease-Specific Trends
The American Cancer Society’s annual report approximates the new cancer diagnoses and deaths expected in 2021 and identifies impactful patterns in oncology care.
Symptom Assessment Scores Associated With Unplanned Hospitalizations in Patients With Head and Neck Cancer
Population-based study demonstrated an association between patient-reported outcomes and ED visits/unplanned hospitalizations among patients with head and neck cancer.
Prolonged-Duration Chemoprophylaxis Decreased VTE in Patients Undergoing Surgery for Head and Neck Cancer
Researchers sought to determine the effect of PDC on venous thromboembolism and bleeding events in patients with HNC undergoing surgery.
Relationship Observed Between Pretreatment Cachexia and Survival Outcomes With Esophagogastric Cancer
Patient-reported outcomes reports regarding weight loss and dietetic interventions showed dietetic consultations improved OS.
Factors Identified for Poor Long-Term Survival in RT-Treated Patients With Oropharyngeal Cancer
This analysis identified the factors for poor long-term survival in radiotherapy (RT)-treated patients with oropharyngeal cancer (OPC).
Gavreto Gets Accelerated Approval for RET-Altered Thyroid Cancers
The approval was based on data from the phase 1/2 ARROW trial which evaluated the efficacy and safety of Gavreto in patients with RET-mutant MTC.
-
Loading...
-
Loading...
Next post in Head and Neck Cancer
